SPI Extra
5.105,16
PKT
+25,42
PKT
+0,50
%
Werbung
Analysen zu SPI Extra-Werten
Datum | Rating | Analyst | |
---|---|---|---|
28.02.05 | Schlatter Industries Market Perform | Vontobel | |
25.02.05 | APG SGA Accumulate | Helvea | |
25.02.05 | Temenos Market Outperform | Vontobel | |
25.02.05 | Komax Neutral | Sarasin Research | |
23.02.05 | Inficon Market Outperform | Vontobel | |
24.02.05 | Temenos Neutral | Credit Suisse First Boston | |
25.02.05 | OC Oerlikon Neutral | Helvea | |
23.02.05 | Sulzer Buy | Sarasin Research | |
23.02.05 | Schindler Buy | Sarasin Research | |
23.02.05 | ALSO Neutral | Sarasin Research | |
25.02.05 | Rieter Buy | Helvea | |
25.02.05 | Schweiter Accumulate | Helvea | |
21.02.05 | Straumann Outperform | Goldman Sachs | |
23.02.05 | Inficon Buy | Sarasin Research | |
21.02.05 | ALSO Neutral | Sarasin Research | |
21.02.05 | Straumann Accumulate | Helvea | |
21.02.05 | Straumann Underweight | Lehman Brothers | |
18.02.05 | TX Group Neutral | Sarasin Research | |
18.02.05 | dormakaba Neutral | Sarasin Research | |
17.02.05 | Lonza Reduce | Sarasin Research | |
18.02.05 | Inficon Buy | Sarasin Research | |
18.02.05 | ALSO Neutral | Sarasin Research | |
17.02.05 | Straumann Outperform | Credit Suisse First Boston | |
18.02.05 | Lonza Buy | Helvea | |
18.02.05 | Inficon Neutral | Helvea | |
17.02.05 | Kuros (Kuros Biosciences) Neutral | Helvea | |
16.02.05 | Lonza Buy | Helvea | |
16.02.05 | TX Group Neutral | Sarasin Research | |
15.02.05 | Swatch (I) Neutral | JP Morgan | |
14.02.05 | OC Oerlikon Reduce | Sarasin Research | |
14.02.05 | Swatch (I) Sector Outperform | Vontobel | |
11.02.05 | Valora Neutral | Sarasin Research | |
14.02.05 | Inficon Buy | Sarasin Research | |
10.02.05 | dormakaba Neutral | Sarasin Research | |
09.02.05 | Jungfraubahn Market Outperform | Vontobel | |
09.02.05 | Logitech Neutral | Sarasin Research | |
09.02.05 | Swatch (I) Buy | Sarasin Research | |
08.02.05 | Adecco SA Neutral | Sarasin Research | |
07.02.05 | Galenica Market Perform | Vontobel | |
04.02.05 | Swatch (N) Outperform | Goldman Sachs |